Dalian Tianchi Jiulong Pharmaceutical Technology Co., Ltd. was founded in 2018 and is a national high-tech enterprise invested by natural persons, venture capital funds, and state-owned companies. It owns 10 national invention patents with independent intellectual property rights and 8 scientific and technological achievements. The company has established the Henan Province Handicapped Chemistry New Material Engineering Technology Research Center and is a key listed reserve enterprise in Henan Province. The company has two modern production bases: Puyang Tianjian Biotechnology Co., Ltd. and Tianchi Pharmaceutical Co., Ltd. As the initial base of Tianchi Pharmaceutical, it has defined the development direction of an innovative and green fine chemical enterprise, continuously developing fields such as advanced pharmaceutical intermediates, chiral resolution agents, electronic and polymer new materials, and has established close cooperation with many multinational chemical companies. It creates sustainable development and value for all stakeholders in the industry. The company pursues excellence, quality, core competitiveness, and social responsibility, and adheres to the corporate mission of using science and innovation to benefit humanity. It is willing to cooperate sincerely with domestic and international customers to create brilliant achievements together! Today's Tianchi Pharmaceutical has established close cooperative relationships with universities, research institutes, and related industry leaders both domestically and internationally. It is striving solidly towards several sub-products in the three major categories of pharmaceuticals, pesticides, and new materials, aiming to develop into one of the top 100 chemical enterprises in China. In the future, Tianchi Pharmaceutical will continue to adhere to the strategy of modernization, intelligence, and serialization, oriented by market demand and driven by scientific and technological innovation. It will continue to rely on its own advantages to conduct in-depth research and development in forward-looking and application fields, explore the future chemical and new material fields, strengthen its strengths, and strive to be a leader in the industry. Focus: Advanced pharmaceutical intermediates, chiral resolution agents, D-amino acids, pesticide intermediates, polymer new materials. We pursue excellence in quality, core competitiveness, and social responsibility, adhere to the corporate mission of using science and innovation to benefit humanity, and are willing to cooperate sincerely with domestic and international customers to create brilliant achievements together!